Filing Details
- Accession Number:
- 0000950170-24-111052
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-10-01 19:55:33
- Reporting Period:
- 2024-09-27
- Accepted Time:
- 2024-10-01 19:55:33
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1088856 | Corcept Therapeutics Inc | CORT | Pharmaceutical Preparations (2834) | 770487658 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1529655 | Charles Gary Robb | C/O Corcept Therapeutics Incorporated 101 Redwood Shores Parkway Redwood City CA 94065 | Chief Business Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2024-09-27 | 415 | $0.00 | 9,665 | No | 4 | G | Indirect | Custodial Account for Child |
| Common Stock | Acquisiton | 2024-09-27 | 415 | $0.00 | 9,665 | No | 4 | G | Indirect | Custodial Account for Child |
| Common Stock | Acquisiton | 2024-10-01 | 11,000 | $3.29 | 33,772 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2024-10-01 | 11,000 | $46.28 | 22,772 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | G | Indirect | Custodial Account for Child |
| No | 4 | G | Indirect | Custodial Account for Child |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock option (right to buy) | Disposition | 2024-10-01 | 11,000 | $0.00 | 11,000 | $3.29 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 14,037 | 2025-02-18 | No | 4 | M | Direct |
Footnotes
- These shares are held by a child of the Reporting Person through a custodial account under the Uniform Transfers to Minors Act for which the Reporting Person is custodian.
- Includes 638 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on December 1, 2023, 697 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on March 1, 2024, 1,818 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on June 3, 2024 and 503 shares underlying unvested restricted stock awards granted to the Reporting Person by the Issuer on September 3, 2024. 100% of the shares underlying the restricted stock awards will vest on the one-year anniversary of the grant date provided the Reporting Person satisfies certain requirements.
- The transaction was made pursuant to a 10b5-1 plan in effect at the time of this transaction.
- Full exercisable.
Billionaire Hedge Funds
